← Eichor
Study identifier: NCT05579366 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Condition: High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma  ·  Sponsor: Genmab

PhasePhase 1/Phase 2
Planned participants884
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable).

This description comes directly from the study's public registry record.

Talk to the study team

Genmab Trial Information  ·  +4570202728  ·  clinicaltrials@genmab.com

Always discuss trial participation with your own doctor first.

Locations (66)

USOR HonorHealthPhoenix, Arizona, United StatesRecruiting
USOR Arizona Oncology AssociatesTucson, Arizona, United StatesRecruiting
University of California Los Angeles Medical CenterLos Angeles, California, United StatesRecruiting
University of California, San Diego; Moores Cancer CenterSan Diego, California, United StatesRecruiting
USOR Sansum ClinicSanta Barbara, California, United StatesRecruiting
Providence Medical FoundationSanta Rosa, California, United StatesRecruiting
USOR Florida Cancer Specialists SouthFort Myers, Florida, United StatesRecruiting
USOR Florida Cancer Specialists NorthSt. Petersburg, Florida, United StatesRecruiting
USOR Florida Cancer Specialists EastWest Palm Beach, Florida, United StatesRecruiting
Augusta University Georgia Cancer CenterAugusta, Georgia, United StatesRecruiting
University of Kansas Medical Center (KUMC)Westwood, Kansas, United StatesRecruiting
USOR Maryland Oncology HematologyRockville, Maryland, United StatesRecruiting

+ 54 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05579366